China National Accord Medicines Corp Ltd (000028) - Cash Flow Conversion Efficiency
Based on the latest financial reports, China National Accord Medicines Corp Ltd (000028) has a cash flow conversion efficiency ratio of -0.020x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥-425.23 Million ≈ $-62.23 Million USD) by net assets (CN¥21.55 Billion ≈ $3.15 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
China National Accord Medicines Corp Ltd - Cash Flow Conversion Efficiency Trend (1998–2024)
This chart illustrates how China National Accord Medicines Corp Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read China National Accord Medicines Corp Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
China National Accord Medicines Corp Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China National Accord Medicines Corp Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
IMAX Corporation
F:IMA
|
0.155x |
|
Recursion Pharmaceuticals Inc
NASDAQ:RXRX
|
-0.112x |
|
360 Finance Inc
NASDAQ:QFIN
|
0.103x |
|
Adecoagro S.A
F:ACD
|
0.021x |
|
Vishay Intertechnology Inc
NYSE:VSH
|
0.013x |
|
PSK Inc
KQ:319660
|
-0.026x |
|
Gas Malaysia Bhd
KLSE:5209
|
0.049x |
|
Gujarat State Petronet Limited
NSE:GSPL
|
0.104x |
Annual Cash Flow Conversion Efficiency for China National Accord Medicines Corp Ltd (1998–2024)
The table below shows the annual cash flow conversion efficiency of China National Accord Medicines Corp Ltd from 1998 to 2024. For the full company profile with market capitalisation and key ratios, see how much is China National Accord Medicines Corp Ltd worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥20.76 Billion ≈ $3.04 Billion |
CN¥3.27 Billion ≈ $478.72 Million |
0.158x | +12.58% |
| 2023-12-31 | CN¥20.98 Billion ≈ $3.07 Billion |
CN¥2.94 Billion ≈ $429.80 Million |
0.140x | +6.33% |
| 2022-12-31 | CN¥19.44 Billion ≈ $2.85 Billion |
CN¥2.56 Billion ≈ $374.67 Million |
0.132x | +43.38% |
| 2021-12-31 | CN¥18.02 Billion ≈ $2.64 Billion |
CN¥1.66 Billion ≈ $242.21 Million |
0.092x | +3.22% |
| 2020-12-31 | CN¥16.89 Billion ≈ $2.47 Billion |
CN¥1.50 Billion ≈ $219.90 Million |
0.089x | -31.68% |
| 2019-12-31 | CN¥15.36 Billion ≈ $2.25 Billion |
CN¥2.00 Billion ≈ $292.71 Million |
0.130x | +36.93% |
| 2018-12-31 | CN¥13.91 Billion ≈ $2.03 Billion |
CN¥1.32 Billion ≈ $193.54 Million |
0.095x | -26.54% |
| 2017-12-31 | CN¥9.93 Billion ≈ $1.45 Billion |
CN¥1.29 Billion ≈ $188.08 Million |
0.129x | -21.63% |
| 2016-12-31 | CN¥8.91 Billion ≈ $1.30 Billion |
CN¥1.47 Billion ≈ $215.48 Million |
0.165x | -12.25% |
| 2015-12-31 | CN¥5.57 Billion ≈ $814.55 Million |
CN¥1.05 Billion ≈ $153.35 Million |
0.188x | +214.64% |
| 2014-12-31 | CN¥4.85 Billion ≈ $709.89 Million |
CN¥-796.70 Million ≈ $-116.58 Million |
-0.164x | -181.81% |
| 2013-12-31 | CN¥2.32 Billion ≈ $339.00 Million |
CN¥465.03 Million ≈ $68.05 Million |
0.201x | +13.95% |
| 2012-12-31 | CN¥1.84 Billion ≈ $269.11 Million |
CN¥323.96 Million ≈ $47.40 Million |
0.176x | +10.57% |
| 2011-12-31 | CN¥1.43 Billion ≈ $208.79 Million |
CN¥227.32 Million ≈ $33.26 Million |
0.159x | -57.90% |
| 2010-12-31 | CN¥1.13 Billion ≈ $165.57 Million |
CN¥428.16 Million ≈ $62.65 Million |
0.378x | +22.69% |
| 2009-12-31 | CN¥878.13 Million ≈ $128.50 Million |
CN¥270.85 Million ≈ $39.63 Million |
0.308x | -18.77% |
| 2008-12-31 | CN¥649.37 Million ≈ $95.02 Million |
CN¥246.58 Million ≈ $36.08 Million |
0.380x | +124.10% |
| 2007-12-31 | CN¥517.58 Million ≈ $75.74 Million |
CN¥87.70 Million ≈ $12.83 Million |
0.169x | -55.91% |
| 2006-12-31 | CN¥472.90 Million ≈ $69.20 Million |
CN¥181.73 Million ≈ $26.59 Million |
0.384x | +2.04% |
| 2005-12-31 | CN¥393.72 Million ≈ $57.61 Million |
CN¥148.28 Million ≈ $21.70 Million |
0.377x | +3.53% |
| 2004-12-31 | CN¥358.20 Million ≈ $52.42 Million |
CN¥130.30 Million ≈ $19.07 Million |
0.364x | +53.55% |
| 2003-12-31 | CN¥342.86 Million ≈ $50.17 Million |
CN¥81.22 Million ≈ $11.89 Million |
0.237x | +175.64% |
| 2002-12-31 | CN¥334.70 Million ≈ $48.98 Million |
CN¥28.76 Million ≈ $4.21 Million |
0.086x | -55.98% |
| 2001-12-31 | CN¥364.45 Million ≈ $53.33 Million |
CN¥71.16 Million ≈ $10.41 Million |
0.195x | +828.36% |
| 2000-12-31 | CN¥405.06 Million ≈ $59.27 Million |
CN¥8.52 Million ≈ $1.25 Million |
0.021x | -58.36% |
| 1999-12-31 | CN¥452.23 Million ≈ $66.18 Million |
CN¥22.84 Million ≈ $3.34 Million |
0.051x | +334.65% |
| 1998-12-31 | CN¥448.25 Million ≈ $65.59 Million |
CN¥5.21 Million ≈ $762.12K |
0.012x | -- |
About China National Accord Medicines Corp Ltd
China National Accord Medicines Corporation Ltd. engages in the retail and distribution of pharmaceutical products in China and internationally. The company offers prescription drugs for various illnesses and medications requiring long-term use, such as oncology, liver disease, neurology, psychiatry, cardiovascular, and rheumatology/immunology. It also provides traditional Chinese medicine, Weste… Read more